The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT04585750 |
|
Recruitment Status :
Recruiting
First Posted : October 14, 2020
Last Update Posted : May 8, 2024
|
Sponsor:
PMV Pharmaceuticals, Inc
Collaborator:
Merck Sharp & Dohme LLC
Information provided by (Responsible Party):
PMV Pharmaceuticals, Inc
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Recruiting |
|---|---|
| Estimated Primary Completion Date : | March 17, 2026 |
| Estimated Study Completion Date : | July 14, 2026 |